Inventor · disambiguated record
Murat V. Kalayoglu
Also filed as: KALAYOGLU MURAT V
24 granted patents·21 pending applications·234 citations·filing 2004–2024
96Inventor score
Files withTOPOKINE THERAPEUTICS INC29CARTESIAN THERAPEUTICS INC7KALAYOGLU MURAT V4SINGER MICHAEL S2GROSSKREUTZ CYNTHIA L1
Top patents by PatentIndex Score
45 records- 0196US8426471B1Methods and compositions for reducing body fat and adipocytesKALAYOGLU MURAT V·Filed 2012·Granted Apr 23, 2013·37 cites·10 claims
- 0295US8569376B2Methods and compositions for reducing body fat and adipocytesTOPOKINE THERAPEUTICS INC·Filed 2013·Granted Oct 29, 2013·23 cites·15 claims
- 0394US10934337B2Anti-BCMA chimeric antigen receptorsCARTESIAN THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·8 cites·30 claims
- 0494US9795614B2Compositions and methods for reducing body fatTOPOKINE THERAPEUTICS INC·Filed 2016·Granted Oct 24, 2017·13 cites·18 claims
- 0594US9040584B2Compositions for topical delivery of prostaglandins to subcutaneous fatTOPOKINE THERAPEUTICS INC·Filed 2014·Granted May 26, 2015·17 cites·20 claims
- 0693US9421215B2Compositions and methods for reducing body fatTOPOKINE THERAPEUTICS INC·Filed 2015·Granted Aug 23, 2016·9 cites·20 claims
- 0793US8877807B2Compositions and methods for reducing body fatTOPOKINE THERAPEUTICS INC·Filed 2014·Granted Nov 4, 2014·15 cites·25 claims
- 0892US9180130B2Tafluprost and analogs thereof for reducing fatTOPOKINE THERAPEUTICS INC·Filed 2012·Granted Nov 10, 2015·11 cites·20 claims
- 0992US9144574B2Compositions and methods for reducing body fatTOPOKINE THERAPEUTICS INC·Filed 2014·Granted Sep 29, 2015·11 cites·19 claims
- 1091US10188661B2Topical dosage regimenTOPOKINE THERAPEUTICS INC·Filed 2015·Granted Jan 29, 2019·12 cites·20 claims
- 1191US9820993B2Methods and compositions for topical delivery of prostaglandins to subcutaneous fatTOPOKINE THERAPEUTICS INC·Filed 2014·Granted Nov 21, 2017·5 cites·21 claims
- 1291US9089579B2Methods and compositions for treating metabolic syndromeKALAYOGLU MURAT V·Filed 2012·Granted Jul 28, 2015·15 cites·10 claims
- 1391US8829050B2Compositions and methods for reducing body fatGROSSKREUTZ CYNTHIA L·Filed 2010·Granted Sep 9, 2014·18 cites·25 claims
- 1491US8778981B2Methods and compositions for locally increasing body fatTOPOKINE THERAPEUTICS INC·Filed 2013·Granted Jul 15, 2014·15 cites·20 claims
- 1588US9849179B2Methods for topical delivery of prostaglandins to subcutaneous fatTOPOKINE THERAPEUTICS INC·Filed 2015·Granted Dec 26, 2017·5 cites·28 claims
- 1687US2024122943A1Methods and compositions for reducing body fat and adipocytesTOPOKINE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1786US9861641B2Methods for reducing body fat using tafluprost and analogs thereofTOPOKINE THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·3 cites·20 claims
- 1886US9504695B2Methods for reducing body fatTOPOKINE THERAPEUTICS INC·Filed 2014·Granted Nov 29, 2016·6 cites·11 claims
- 1986US2024122942A1Methods and compositions for reducing body fat and adipocytesTOPOKINE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2085US11220535B2Anti-BCMA chimeric antigen receptorsCARTESIAN THERAPEUTICS INC·Filed 2021·Granted Jan 11, 2022·1 cites·30 claims
- 2184US10869874B2Methods and compositions for topical delivery of prostaglandins to subcutaneous fatTOPOKINE THERAPEUTICS INC·Filed 2017·Granted Dec 22, 2020·1 cites·22 claims
- 2283US10285995B2Compositions and methods for reducing body fatTOPOKINE THERAPEUTICS INC·Filed 2017·Granted May 14, 2019·2 cites·22 claims
- 2382US10556012B2Compositions and methods for topical delivery of prostaglandins to subcutaneous fatTOPOKINE THERAPEUTICS INC·Filed 2017·Granted Feb 11, 2020·2 cites·27 claims
- 2482US8883834B2Methods and compositions for locally increasing body fatTOPOKINE THERAPEUTICS INC·Filed 2014·Granted Nov 11, 2014·4 cites·20 claims
- 2581US2024294600A1Anti-bcma chimeric antigen receptorsCARTESIAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2680US2023330105A1Methods and compositions for topical delivery of prostaglandins to subcutaneous fatTOPOKINE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2777US2021393648A1Methods and compositions for reducing body fat and adipocytesTOPOKINE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2876US2022152206A1Compositions and methods for topical delivery of prostaglandins to subcutaneous fatTOPOKINE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2976US2021308143A1Compositions and methods for reducing body fatTOPOKINE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3075US11999773B2Anti-BCMA chimeric antigen receptorsCARTESIAN THERAPEUTICS INC·Filed 2021·Granted Jun 4, 2024·0 cites·10 claims
- 3175US10335418B2Methods and compositions for treating metabolic syndromeTOPOKINE THERAPEUTICS INC·Filed 2016·Granted Jul 2, 2019·1 cites·12 claims
- 3270US2021213032A1Methods and compositions for topical delivery of prostaglandins to subcutaneous fatTOPOKINE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3369US2020069699A1Compositions and methods for reducing body fatTOPOKINE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3469US2020282059A1Compositions and methods for topical delivery of prostaglandins to subcutaneous fatTOPOKINE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3566US2018353517A1Methods and compositions for reducing body fat and adipocytesTOPOKINE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3661US2024344030A1Multiprotein-engineered cells secreting a multispecific antibodyCARTESIAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3760US2010215639A1Chlamydia Pneumoniae Associated Chronic Intraocular Disorders and Treatment ThereofKALAYOGLU MURAT V·Filed 2009·Application pending·0 cites
- 3857US2010015584A1Behavior Modification with Intermittent RewardSINGER MICHAEL S·Filed 2009·Application pending·0 cites
- 3956US2013034588A1Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereofMASSACHUSETTS EYE AND EAR IN RY FA·Filed 2012·Application pending·0 cites
- 4053US2006141470A1Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereofKALAYOGLU MURAT V·Filed 2004·Application pending·0 cites
- 4153US2011104648A1Systems and methods for health behavior reinforcementHEALTHHONORS CORP·Filed 2010·Application pending·0 cites
- 4252US2023174944A1Engineered cells secreting therapeutic enzymesCARTESIAN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4343US2016206606A1Topical compositions comprising a thiazolidinedioneTOPOKINE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4442US2008077430A1Systems and methods for improving medication adherenceSINGER MICHAEL S·Filed 2006·Application pending·0 cites
- 4540US2019030073A1Cancer immunotherapy with highly enriched cd8+ chimeric antigen receptor t cellsCARTESIAN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Murat V. Kalayoglu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →